JAMA Network Open, 13 May 2019 This cohort study identifies factors associated with the adoption of sipuleucel-T to treat US patients with asymptomatic or…
JAMA Network Open, 24 Apr 2019 Cohort study finds income, geography, and clinician specialty independently associated with receiving sipuleucel-T for prostate…